British pharmaceutical giant GSK committed to investing at least $30 billion in U.S. research and developing and manufacturing over the next five years.
25 Years After 9/11: America Remembers as Victim Toll Grows
25 years after 9/11, America remembers nearly 3,000 victims as thousands more deaths are linked to long-term illnesses from toxic exposure.
0 Comments